Plain-English translation of NCT07537673 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a combination approach to prevent nausea and vomiting in breast cancer patients receiving trastuzumab deruxtecan, a powerful targeted therapy. The study combines a traditional Chinese medicine technique—applying small seeds to specific points on your ear—with a steroid medication called dexamethasone. The goal is to reduce severe nausea while avoiding the extra side effects that come from using multiple strong anti-nausea drugs.
Most patients receiving this medication experience significant nausea and vomiting, and the standard way to prevent it uses four different types of drugs that can cause their own problems like constipation and loss of appetite. Researchers want to find a gentler way to prevent these symptoms while protecting your overall quality of life and ability to continue treatment.
You likely qualify if…
You likely don't qualify if…
You will receive small seeds (called Vaccaria seeds) taped to specific points on your ear within 30 minutes before your chemotherapy treatment begins. You'll also receive a steroid injection called dexamethasone. The seeds stay on your ear for five days (from the day of treatment through day 5), and you'll apply gentle pressure to them several times a day to stimulate the acupressure points. The study team will monitor how well this combination prevents nausea and vomiting compared to standard treatment.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
China